Federal prosecutors have pursued a "massive" investigation of off-label marketing of drugs at GlaxoSmithKline, and the indictment of a former associate GC is "just a small piece of it," according to a defense attorney.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *